Ebola’s Spread Sparks Debate on Developmental Medicines

July 10, 2014, 9:29 a.m.

Spe­cial­ists are de­bat­ing calls to em­ploy de­vel­op­ment­al medi­cines against an Ebola out­break ravaging West Africa, the Ca­na­dian Press re­ports.

A num­ber of ana­lysts said dis­trib­ut­ing vac­cines or drug treat­ments that are not fully tested may boost loc­al dis­trust of of­fi­cials that have been fight­ing the spread of Ebola hem­or­rhagic fever since March, the news agency re­por­ted on Wed­nes­day. No fully vet­ted medi­cines cur­rently ex­ist for the dis­ease, which as of Tues­day may have killed more than 500 people in Guinea, Liber­ia and Si­erra Le­one.

Ac­cord­ing to some op­pon­ents of us­ing such medi­cines, any ad­verse side ef­fects may threaten years of ef­forts to de­vel­op the drugs as a de­fense against the po­ten­tial bio­lo­gic­al-weapon agent.

“It would be un­eth­ic­al to roll [de­vel­op­ment­al medi­cines] out now, in my opin­ion,” said Dav­id Hey­mann, a former World Health Or­gan­iz­a­tion as­sist­ant dir­ect­or gen­er­al.

Of­fi­cials could in­stead move, once the cur­rent threat sub­sides, to lay the ground­work for us­ing such treat­ments to com­bat fu­ture out­breaks, Hey­mann ar­gued. The World Health Or­gan­iz­a­tion could make such policy pre­par­a­tions in col­lab­or­a­tion with drug de­velopers and re­gion­al gov­ern­ments, he said.

One ex­pert, though, pressed for im­me­di­ately us­ing Ebola coun­ter­meas­ures now in a late stage of de­vel­op­ment.

“Ima­gine if you take a re­gion of Canada, Amer­ica, Europe and you had 450 people dy­ing of a vir­al hem­or­rhagic fever. It would just be un­ac­cept­able — and it’s un­ac­cept­able in West Africa,” said Jeremy Far­rar, a trop­ic­al medi­cine and glob­al health spe­cial­ist at Ox­ford Uni­versity.

What We're Following See More »
BARR PLANS TO SEND CONGRESS A SUMMARY
Mueller Report Almost Done
5 hours ago
THE DETAILS

“Attorney General Bill Barr is preparing to announce as early as next week the completion of Robert Mueller's Russia investigation, with plans for Barr to submit to Congress soon after a summary of Mueller's confidential report. ... The preparations are the clearest indication yet that Mueller is nearly done with his almost two-year investigation. The precise timing of the announcement is subject to change. The scope and contours of what Barr will send to Congress remain unclear.”

IN UNANIMOUS DECISION
SCOTUS Limits State and Local Governments' Ability to Levy Fines
7 hours ago
THE DETAILS

"The U.S. Supreme Court curbed the power of cities and states to levy fines and seize property, siding with a man trying to keep his Land Rover after he pleaded guilty to selling drugs. The unanimous ruling marks the first time the court has said that states and cities are bound by the Constitution’s ban on excessive fines, part of the Eighth Amendment."

Source:
AFTER U.S. WITHDRAWS FROM INF TREATY
Putin Threatens Arms Race
8 hours ago
THE LATEST

"Moscow will match any U.S. move to deploy new nuclear missiles closer to Russia by stationing its own missiles closer to the United States or by deploying faster missiles or both, President Vladimir Putin said on Wednesday. Putin said Russia was not seeking confrontation and would not take the first step to deploy missiles in response to Washington’s decision this month to quit a landmark Cold War-era arms control treaty."

Source:
MAY 26-28
Trump to Visit Japan
8 hours ago
THE LATEST
AVOIDS SHUTDOWN WITH A FEW HOURS TO SPARE
Trump Signs Border Deal
5 days ago
THE LATEST

"President Trump signed a sweeping spending bill Friday afternoon, averting another partial government shutdown. The action came after Trump had declared a national emergency in a move designed to circumvent Congress and build additional barriers at the southern border, where he said the United States faces 'an invasion of our country.'"

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login